Tag Archives: BMS
By Guest Blogger | Published: September 21, 2012
By Amy Ritter. Ten biopharmaceutical companies announced the formation of a nonprofit organization called TransCelerate BioPharma, the mission of which is to accelerate the development of new medicines by identifying and solving common drug development challenges.
By Walter Armstrong | Published: June 9, 2009
Media wordsmiths are competing to outdo one another today in punny reporting on the news that ex-BMS exec Andrew Bodnar has been sentenced to write a book about the role he played in the firmâ€™s 2006 reverse-payments case over generic Plavix. â€œPen-ance: Bristol-Myers Exec Gets Two Years of Hard Writing,â€ The Wall Street Journal Law Blog [...]
By George Koroneos | Published: September 10, 2008
In a statement to the press today, ImClone Chairman Carl Icahn said that the review committee overlooking Bristol-Myers Squibbâ€™s offer to purchase the biotech company for $60 per share $4.5 billion just isnâ€™t good enough. He not only accused BMS of lowballing, but also admitted that the company has been in talks with the head of [...]